The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.

At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

Privately-held Swedish firm Salipro Biotech AB, a specialist in the stabilization of challenging drug targets, today ...

Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...

BlackLine, Inc. , the intelligent financial data platform that powers the modern Office of the CFO, has announced the winners of its 2024 Global and Regional Partner Awards, celebrating firms that ...

Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...

NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Nexxen, a global, unified advertising technology platform with deep expertise in data and advanced TV, today announced the appointment of four new ...

Syra Health Corp. , a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health ...

The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...